S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   115.19 (+2.59%)
MSFT   210.28 (+1.18%)
FB   257.65 (+1.11%)
GOOGL   1,462.64 (+1.64%)
AMZN   3,178.70 (+2.70%)
TSLA   420.93 (+3.34%)
NVDA   522.15 (+1.40%)
BABA   275.70 (+1.70%)
CGC   14.24 (+0.49%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.56 (+1.92%)
T   28.38 (+1.21%)
F   6.70 (+2.92%)
ACB   4.77 (-5.54%)
GILD   62.93 (+1.09%)
NFLX   491.58 (+1.80%)
DIS   126.00 (+1.61%)
BA   165.93 (+6.34%)
BAC   24.11 (+2.64%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   115.19 (+2.59%)
MSFT   210.28 (+1.18%)
FB   257.65 (+1.11%)
GOOGL   1,462.64 (+1.64%)
AMZN   3,178.70 (+2.70%)
TSLA   420.93 (+3.34%)
NVDA   522.15 (+1.40%)
BABA   275.70 (+1.70%)
CGC   14.24 (+0.49%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.56 (+1.92%)
T   28.38 (+1.21%)
F   6.70 (+2.92%)
ACB   4.77 (-5.54%)
GILD   62.93 (+1.09%)
NFLX   491.58 (+1.80%)
DIS   126.00 (+1.61%)
BA   165.93 (+6.34%)
BAC   24.11 (+2.64%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   115.19 (+2.59%)
MSFT   210.28 (+1.18%)
FB   257.65 (+1.11%)
GOOGL   1,462.64 (+1.64%)
AMZN   3,178.70 (+2.70%)
TSLA   420.93 (+3.34%)
NVDA   522.15 (+1.40%)
BABA   275.70 (+1.70%)
CGC   14.24 (+0.49%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.56 (+1.92%)
T   28.38 (+1.21%)
F   6.70 (+2.92%)
ACB   4.77 (-5.54%)
GILD   62.93 (+1.09%)
NFLX   491.58 (+1.80%)
DIS   126.00 (+1.61%)
BA   165.93 (+6.34%)
BAC   24.11 (+2.64%)
S&P 500   3,351.60 (+1.61%)
DOW   27,584.06 (+1.51%)
QQQ   277.20 (+2.08%)
AAPL   115.19 (+2.59%)
MSFT   210.28 (+1.18%)
FB   257.65 (+1.11%)
GOOGL   1,462.64 (+1.64%)
AMZN   3,178.70 (+2.70%)
TSLA   420.93 (+3.34%)
NVDA   522.15 (+1.40%)
BABA   275.70 (+1.70%)
CGC   14.24 (+0.49%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.56 (+1.92%)
T   28.38 (+1.21%)
F   6.70 (+2.92%)
ACB   4.77 (-5.54%)
GILD   62.93 (+1.09%)
NFLX   491.58 (+1.80%)
DIS   126.00 (+1.61%)
BA   165.93 (+6.34%)
BAC   24.11 (+2.64%)
Log in
NASDAQ:LGND

Ligand Pharmaceuticals Short Interest Ratio and Short Volume

$95.75
-1.43 (-1.47 %)
(As of 09/28/2020 04:30 PM ET)
Add
Compare
Today's Range
$95.15
Now: $95.75
$99.13
50-Day Range
$89.56
MA: $104.60
$118.66
52-Week Range
$57.24
Now: $95.75
$127.80
Volume191,931 shs
Average Volume390,674 shs
Market Capitalization$1.54 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.45

Short Interest

Ligand Pharmaceuticals (NASDAQ:LGND) Short Interest Data

Current Short Volume:9,280,000 shares
Previous Short Volume:9,010,000 shares
Change Vs. Previous Month:+3.00%
Dollar Volume Sold Short:$901.83 million
Short Interest Ratio / Days to Cover:35.0
Last Record Date:September, 15 2020
Outstanding Shares:19,600,000 shares
Float Size:15,430,000 shares
Short Percent of Float:60.14%
Today's Trading Volume:191,931 shares
Average Trading Volume:390,674 shares
Today's Volume Vs. Average:-50.87%



Ligand Pharmaceuticals (NASDAQ:LGND) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
9/15/20209,280,000 $901.83 million 3.0%60.1%35$97.18
8/31/20209,010,000 $912.08 million 0.9%58.4%34.6$101.23
8/14/20208,930,000 $908.98 million 4.6%57.9%31.6$101.79
7/31/20208,540,000 $999.44 million -3.3%55.5%27.5$117.03
7/15/20208,830,000 $1.03 billion -1.9%57.3%26.7$117.18
6/30/20209,000,000 $1.08 billion -4.8%58.3%24.6$119.76
6/15/20209,450,000 $1.06 billion 2.1%61.2%22.3$111.91
5/29/20209,260,000 $1.02 billion -1.9%59.7%17.9$110.01
5/15/20209,440,000 $958.82 million 2.8%60.9%16.8$101.57
4/30/20209,180,000 $961.79 million -2.9%59.2%16.3$104.77
4/15/20209,450,000 $1.01 billion 2.2%59.7%17.1$106.64
3/31/20209,250,000 $903.08 million 3.9%58.4%17.1$97.63
3/13/20208,904,900 $769.56 million 12.6%56.1%14.1$86.42
2/28/20207,910,000 $557.97 million 3.1%49.8%20.8$70.54
2/14/20207,670,000 $752.58 million -0.1%45.4%24.4$98.12
1/31/20207,680,000 $788.12 million -0.9%45.3%24.3$102.62
1/15/20207,750,000 $734.39 million -0.3%45.7%23.8$94.76
12/31/20197,770,000 $687.96 million 1.0%45.8%25$88.54

Ligand Pharmaceuticals (NASDAQ:LGND) Short Interest FAQ

speech bubbles
speech bubbles











What is Ligand Pharmaceuticals' current short interest?

Short interest is the volume of Ligand Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 9,280,000 shares of LGND short. 60.14% of Ligand Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest ratio for Ligand Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Ligand Pharmaceuticals currently has a short interest ratio of 35.0.

What is a good short interest percentage for Ligand Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 60.14% of Ligand Pharmaceuticals' floating shares are currently sold short.

Is Ligand Pharmaceuticals' short interest increasing or decreasing?

Ligand Pharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 9,280,000 shares, an increase of 3.0% from the previous total of 9,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Ligand Pharmaceuticals' float size?

Ligand Pharmaceuticals currently has issued a total of 16,078,000 shares. Some of Ligand Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ligand Pharmaceuticals currently has a public float of 15,430,000 shares.

How does Ligand Pharmaceuticals' short interest compare to its competitors?

60.14% of Ligand Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Ligand Pharmaceuticals: Amgen, Inc. (1.16%), Gilead Sciences, Inc. (1.44%), Vertex Pharmaceuticals Incorporated (0.00%), Regeneron Pharmaceuticals Inc (1.57%), Biogen Inc (2.33%), Seattle Genetics, Inc. (0.00%), Alexion Pharmaceuticals, Inc. (2.33%), Immunomedics, Inc. (0.00%), Incyte Co. (0.00%), and Alnylam Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications Inc ($5.17 billion), Aon PLC ($3.57 billion), ViacomCBS Inc. ($3.01 billion), Clorox Co ($2.91 billion), Charles Schwab Co. ($2.80 billion), Mercadolibre Inc ($2.33 billion), Analog Devices, Inc. ($2.14 billion), Kroger Co ($1.99 billion), Moderna Inc ($1.96 billion), and Simon Property Group Inc ($1.80 billion). View all of the most shorted stocks.

What does it mean to sell short Ligand Pharmaceuticals stock?

Short selling LGND is an investing strategy that aims to generate trading profit from Ligand Pharmaceuticals as its price is falling. Ligand Pharmaceuticals' stock is trading down $1.43 today. To short Ligand Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Ligand Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ligand Pharmaceuticals?

A short squeeze for Ligand Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LGND, which in turn drives the price of the stock up even further.

How often is Ligand Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LGND, twice per month. The most recent reporting period available is September, 15 2020.


This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.